The reclassification is tied to the detection of Listeria monocytogenes, a bacteria that can cause severe illness.
Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore ...
EyeYon Medical says FDA granted IDE for a multicenter study led by Scripps Clinic’s Prof. Francis Mah, with enrollment ...